Postgraduate Course

Merging the Evidence and the Art: The Latest Clinical Practice Updates in Gastroenterology and Hepatology

Course Directors: Christina Y. Ha, MD, FACG, and Colleen R. Kelly, MD, FACG

Sunday, October 23, 2022 │ ALL TIMES ARE LISTED IN THE EASTERN TIME ZONE
7:50 am Introduction by Course Directors
Christina Y. Ha, MD, FACG, and Colleen R. Kelly, MD, FACG
8:00 am Session 2A: GI Bleeding: Diagnosis, Management, Prevention
Moderator: Neena S. Abraham, MD, MSc (Epid), MACG
  • Management of Anticoagulants and Antiplatelets During Acute GI Bleeding
    Neena S. Abraham, MD, MSc (Epid), MACG
    Recognize low-risk versus high-risk patients and endoscopic procedures and properly manage antithrombotic and antiplatelet agents.
  • Upper GI Bleeding
    Loren A. Laine, MD, FACG
    Discuss the initial assessment and risk stratification of patients with UGI bleeding. Define the role of medical therapy and endoscopic modalities to treat UGI bleeding. Discuss the role of repeat endoscopy for patients with evidence of recurrent UGI bleeding.
  • Acute Lower GI Bleeding
    Lisa L. Strate, MD, MPH, FACG
    Define the role of endoscopy, surgery, and interventional radiology in the management of lower GI bleeding.
  • Disorders of the Hepatic and Mesenteric Circulation
    Patrick S. Kamath, MD
    Summarize the presentation and management of vascular disorders of the portal and mesenteric circulation.
  • Panel Q & A
9:40 am Break
10:00 am Session 2B: Maximizing the Yield of the IBD Toolbox
Moderator: Christina Y. Ha, MD, FACG
  • What’s the Goal? Determining the Goals of Care Using Treat-to-Target and Shared Decision-Making Approaches
    Millie D. Long, MD, MPH, FACG
    Describe how to apply a “treat-to-target” strategy from selection to monitoring to optimization for an individual patient to improve outcomes.
  • What Are We Looking At? Endoscopic Features of IBD
    Anita Afzali, MD, MPH, MHCM, FACG
    Explain the endoscopic features of IBD disease activity, post-surgical anatomy including ileocolonic anastomoses and ileal pouches. Describe the features that should be included in a quality IBD endoscopy report.
  • How Does It Work? Describing the Mechanisms and Risks of Treatments to Patients
    Christina Y. Ha, MD, FACG
    Summarize the mechanisms of action, adverse effects and monitoring strategies of the biologics and small molecules in patient-friendly language.
  • Why Choose Surgery? Counseling Patients About the Indications and Role of Surgery in IBD
    Benjamin L. Cohen, MD, MAS
    Identify both patient and disease related factors that should be considered to determine the appropriate time to send a patient to surgery and post-operative surveillance.
  • What Else Do We Need to Do? Health Care Maintenance for IBD Patients
    Freddy Caldera, DO, MS, FACG
    Explain appropriate recommendations and timing for vaccinations, cancer screenings, osteoporosis assessments, and psychosocial care.
  • Panel Q & A
12:00 pm Break for Learning Luncheons
12:20 pm –
1:35 pm
Sunday Learning Luncheons

Separate Purchase Required: You must register for the Postgraduate Course in order to purchase the optional Learning Luncheon Bonus Sessions package. In-person attendees purchasing the package will be able to select a Saturday and a Sunday session during the registration process.

Both in-person and virtual-only attendees will receive access to the faculty presentation slides from ALL 24 Learning Luncheon Bonus Sessions. On-demand Bonus Sessions are pre-recorded narrations by faculty of their presentation slides. These sessions will be available to watch on the ACG 2022 Conference Platform, from late October until March 31, 2023.

  1. Food Allergies vs Sensitivities and Their Role in the GI Tract: Fact or Fiction?
    Brooks D. Cash, MD, FACG
    Identify the latest evidence-based dietary advice for patients with functional GI diseases.
  2. To Capsule or Not to Capsule, What’s the Indication?
    Shirley C. Paski, MD
    Highlight the clinical scenarios where capsule endoscopy is important for clinical decision making.
  3. Pancreatic Cancer: Screening, Surveillance, and Treatment
    Aimee L. Lucas, MD, FACG
    Appraise the need for pancreatic cancer screening in high-risk populations and local treatments for pancreaticobiliary malignancy.
  4. Drug-Induced Liver Injury: Early Identification and Treatment
    Haripriya Maddur, MD
    Summarize the clinical presentation, potential causes, and management of drug-induced liver injury and when to refer for specialized care.
  5. Portal Hypertension Management 101: Best Practices Based on Evidence and Experience
    Patrick S. Kamath, MD
    Describe surveillance, diagnosis, and management strategies for hepatic encephalopathy, varices, and ascites due to cirrhosis/portal hypertension.
  6. Complications of Endoscopic Therapies: See Something, Do Something
    Uzma D. Siddiqui, MD, FACG
    Highlight the key features for early recognition and management of complications of endoscopy therapies including EMR, ESD, POEM, and dilation.
  7. Middle of the Night Emergencies: Things You Need to Get Out of Bed For vs What Can Wait Until Morning
    David A. Greenwald, MD, FACG
    Discuss how to approach and triage GI emergencies such as bleeding, food impactions, foreign bodies, and cholangitis. Consider effective communications over emergency cases and how after-hours care can be optimized.
  8. Breath Testing: A Clinician’s Primer
    William D. Chey, MD, FACG
    Understand the types of breath testing available, both office and home based, and the utility of breath testing in clinical practice for diagnosis of lactose malabsorption, SIBO, and sucrase isomaltase deficiencies.
  9. Making Peace With the Pelvic Floor
    Adil E. Bharucha, MBBS, MD
    Identify patients with pelvic floor dysfunction and develop a treatment plan.
  10. The Reflux Conundrum: The Various Presentations and Mimickers of GERD
    Rena H. Yadlapati, MD, MSHS, FACG
    Outline the evidence-based approach to diagnosing and management of reflux including atypical presentations and non-acid related esophageal symptoms.
  11. Beyond Antibiotics: Evidence-Based and “Outside the Box” Approaches to Management of Ileal Pouch Disorders
    Edward L. Barnes, MD, MPH
    Describe a systematic approach to the diagnosis of pouch-related complications and their management.
  12. Updates in Dysplasia Surveillance in IBD
    Samir A. Shah, MD, FACG
    Provide an overview of the latest clinical practice updates for dysplasia surveillance in IBD including utilization of advanced imaging modalities such as narrow-band imaging and chromoendoscopy.
1:35 pm Break
1:45 pm –
3:00 pm
Simultaneous Symposia

Symposium D: Lumps and Bumps in the GI Tract: Updates From New Guidelines
Moderator: Carol A. Burke, MD, FACG

  • Non-polypoid and Submucosal Masses in the GI Tract
    Vanessa M. Shami, MD, FACG
    Highlight the endoscopic and ultrasonographic features of submucosal masses of the GI tract. Summarize the management and surveillance strategies for the various types of submucosal lesions.
  • GI Polyposis Syndromes
    Carol A. Burke, MD, FACG
    Summarize the recommendations for screening and surveillance of patients with genetic colorectal cancer syndromes.
  • Gastric Premalignant Conditions
    Douglas R. Morgan, MD, MPH, FACG
    Recognize the implications of intestinal metaplasia of the stomach and risk of progression to high-grade dysplasia and cancer. Highlight the risk factors for gastric cancer and surveillance strategies.
  • Panel Q & A

Symposium E: Small Bowel Disorders: More Than Just the Gluten
Moderator: Amy S. Oxentenko, MD, FACG

  • Celiac Disease Update
    Carol E. Semrad, MD, FACG
    Describe the differential diagnosis, testing, surveillance, and management of celiac disease including refractory celiac disease.
  • Enteric Infections and Food-borne Illnesses
    Mark S. Riddle, MD, DrPH, FISTM
    Learn the epidemiology, evaluation, and management of gastroenteritis including both common and rarer pathogens to be aware of.
  • Celiac Mimics and Autoimmune Enteropathies
    Amy S. Oxentenko, MD, FACG
    Appreciate the non-celiac causes of villous blunting as well as evaluation and management of autoimmune enteropathy.
  • Panel Q & A

Symposium F: Gastrointestinal Complications of Oncology Treatments and Palliative Care Options
Moderator: Jennifer C. Lai, MD, MBA

  • Immune Checkpoint Inhibitor Colitis and Other GI-Related Adverse Events
    David M. Faleck, MD
    Describe the mechanisms, presentation, and management of gastrointestinal complications of immune checkpoint inhibitor therapies.
  • Palliative Care in End-Stage Liver Disease
    Jennifer C. Lai, MD, MBA
    Provide recommendations and insights for gastroenterologists on palliative care strategies for end-stage liver disease.
  • Endoscopic Options for Malignant Luminal Obstruction and Bleeding
    Amrita Sethi, MD
    Understand the role of palliative stenting and venting G-tubes in malignant obstruction, nausea, and vomiting. Describe options for management of malignant GI bleeding including vascular interventional and endoscopic therapies.
  • Panel Q & A
3:00 pm Break
3:35 pm Session 2C: What’s New in Functional GI Disorders?
Moderator: Linda Anh B. Nguyen, MD, FACG
  • The Lowdown on the Slowdown: Gastroparesis Updates
    Linda Anh B. Nguyen, MD, FACG
    Describe the clinical presentation, diagnosis, and latest evidence-based management of gastroparesis.
  • Moving Ahead: Best Practices to Addressing Constipation
    William D. Chey, MD, FACG
    Appraise the quality of evidence behind currently available pharmacotherapy for chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).
  • Finishing Strong: Management of Benign Anorectal Disorders
    Adil E. Bharucha, MBBS, MD
    Evaluate the role of pelvic floor dysfunction in chronic constipation, irritable bowel syndrome (IBS) and fecal continence. Summarize the indications and classic findings for anorectal manometry.
  • Panel Q & A
4:55 pm Take-Home Pearls: What Did We Learn Today?
Christina Y. Ha, MD, FACG, and Colleen R. Kelly, MD, FACG
Review important and practical take-home messages from today’s talks.
5:15 pm Postgraduate Course Adjourns